Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Rüdiger E. Port"'
Autor:
Ludwig G. Strauss, Rüdiger E. Port, Matthias E. Bellemann, J. Zaers, Jutta Kissel, Uwe Haberkorn, Gunnar Brix
Publikováno v:
Medical Physics. 26:609-615
For the application of a kinetic model to PET data, it is generally necessary to obtain the arterial input function (AIF). It was the aim of the present study to introduce a method suitable for the determination of the AIF of a substance that undergo
Publikováno v:
Clinical Pharmacology & Therapeutics. 57:325-334
We present a new model-dependent approach to quantify hematologic toxicity in a patient population after anticancer therapy. The population model consists of three submodels that are simultaneously fit to the data: (1) a cubic spline function describ
Publikováno v:
Oncology. 51:510-514
The effect of tetrachlorodecaoxide (TCDO) treatment after total-body irradiation (TBI) with gamma-rays (single dose, about LD 50) on the development of radiation-induced leukemia was tested in rats. TCDO was applied intravenously from day 4 through d
Autor:
P. Steindorfer, K. Stevens, Arnold Lockshin, M. Schmid, Rüdiger E. Port, H. Samonigg, Michael Untch, Ivan G. Strukov, Tatsuhei Kondo, Stan Ivankovic, Osamu Doi, I. Kuss, J. García-Conde, A. Uys, A.K. Kasparek, Shuichi Okada, Tokuhiro Kawashima, Hideoki Yokouchi, S.H. Schmitz, J. Schimke, Masaji Yamauchi, Valentina I. Ryabkova, Miyako Kawashima, Cheppail Ramachandran, W.J.H. Vermaak, E. Derstvenscheg, C. Lackner, Carla I. Falkson, Takuji Okusaka, H. Stöger, Luis Fonseca, Akio Yamaguchi, Yutaka Yonemura, F. Jarque, Roberto Angioli, Shoshana Keren-Rosenberg, Masahiro Kanno, Masahiro Yoshino, Hideki Yokoyama, Mokoto Uogishi, Masayoshi Yoshimori, Masahiko Iwasaki, James P. Perras, M. Wilders-Truschnig, Geoffrey Falkson, Kazunori Aoki, Yoshitaka Sato, Takashi Inoue, Koichi Miwa, Valentina K. Sokolova, Itsuo Miyazaki, Junji Furuse, Albert Steren, T. Bauernhofer, Hiroshi Asoh, Hiroshi Ishii, Xabier De Aretxabala, Hajime Arakawa, Kimio Wada, Masahiko Higashiyama, Kiichi Maeda, Ryuhei Tateishi, Hiroshi Sodani, B.L. Rapoport, R.M. Moser, Ken Kodama, V. Diehl, D.L. Voliotis, A. Lluch, Ossi R. Koechli, Haruhiko Nose, F. Ploner, Yukito Ichinose, Klaus Blaszkiewitz, Hiroyuki Takamura, Nobuko Takanashi, Hervy E. Averette, G. Falkson, E. Vizcarra, R. Cibrián, M. de Wet, Tokujiro Yano, Bernd-Uwe Sevin, Susanne R. Kempf, Hironobu Kimura
Publikováno v:
Oncology. 51:I-VI
Publikováno v:
Clinical Pharmacology and Therapeutics. 49:497-505
Kinetic modeling has been applied to the time course of the nuclear magnetic resonance signal intensities of 5-fluorouracil and the sum of its catabolites, α-fluoro-β-ureido propanoic acid and α-fluoro-β-alanine, as monitored in liver tumors of s
Publikováno v:
Therapeutic Drug Monitoring. 13:96-102
The correlation between single plasma concentration (CP) values of 5-fluorouracil (FU) after a 10-minute i.v. infusion and the total area under the plasma concentration-time curve (AUC) has been studied in 26 cancer patients. FU dose was either 320-5
Publikováno v:
International journal of clinical pharmacology and therapeutics. 43(12)
Publikováno v:
Zeitschrift für Medizinische Physik. 1:119-121
Zusammenfassung Wird fur die dynamische Magnet-Resonanz-Tomographie (MRT) eine Spin-Echo-Sequenz mit einer kurzen Repetitions- und Echozeit verwendet (z.B. SE 100/10 ms), so ist der Signalanstieg nach i.v. Gd-DTPA-Applikation linear mit der lokalen G
Publikováno v:
Journal of magnetic resonance (San Diego, Calif. : 1997). 133(1)
The anticancer drug carboplatin has been monitored in rats during treatment by means of in vivo 195Pt NMR spectroscopy at 2.0 T. The purpose of the study was to assess local disposition kinetics in intact tissue following subcutaneous injection of a
Autor:
Barbara Bertram, Jörg Stüben, Rüdiger E. Port, Marianne Schaper, J. Pohl, Manfred Wiessler, William E. Hull, Ursula Bollow
Publikováno v:
Cancer chemotherapy and pharmacology. 38(4)
beta-D-Glucosylisophosphoramide mustard (beta-D-Glc-IPM) is a new, potential chemotherapeutic agent currently under investigation. Its pharmacokinetics in plasma and elimination of the parent drug and its metabolites via urine, bile, and exhaled air